http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009538822-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-196
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2007-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009538822-A
titleOfInvention Treatment of viruses in veins
abstract The present invention provides unit dosage forms, kits, and methods useful for the treatment of viral infections. One embodiment of the present invention provides a method of treating a human viral infection (eg, influenza infection), wherein the method comprises an amount of a compound of formula I, II, III, or IV having effective antiviral activity. Or administering a pharmaceutically acceptable salt thereof to a human by an intravenous route. The invention also provides a method of inhibiting neuraminidase in the human body, wherein the method comprises an amount of a compound of formula I, II, III, or IV, or a pharmaceutically acceptable amount thereof, with effective inhibitory activity. Administering salt to the human by an intravenous route.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010535820-A
priorityDate 2006-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0197792-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467696147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467696126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467756222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467696139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467756313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467756078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467696106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467756208

Total number of triples: 27.